| Source: |
| Type: |
| Toxicity |
| 7080- | GABA, | The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention |
| - | Review, | AD, | NA |
| 1957- | GamB, | Nanoscale Features of Gambogic Acid Induced ROS-Dependent Apoptosis in Esophageal Cancer Cells Imaged by Atomic Force Microscopy |
| - | in-vitro, | ESCC, | EC9706 |
| 7062- | GamB, | Chit, | Modified chitosan derivative micelle system for natural anti-tumor product gambogic acid delivery |
| - | in-vivo, | Nor, | NA |
| 7061- | GamB, | An open-labeled, randomized, multicentered, phase IIa study for advanced cancer treatment by gambogic acid injection (THS) |
| - | Trial, | Var, | NA |
| 7055- | GamB, | Studies on the toxicity of gambogic acid in rats |
| - | in-vivo, | Nor, | NA |
| 7086- | GAR, | Garcinol: An emerging epigenetic modifier with versatile anticancer properties |
| - | Review, | Var, | NA |
| 7085- | GAR, | Safety profile of 40% Garcinol from Garcinia indica in experimental rodents |
| - | in-vivo, | Nor, | NA |
| 7090- | GAR, | Garcinol |
| 794- | GAR, | Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression |
| - | in-vitro, | RCC, | NA | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | NA |
| 7213- | GAs, | Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90 |
| - | vitro+vivo, | NPC, | CNE2 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Lung, | H1975 |
| 7204- | GAs, | The Pharmacology and Toxicology of Ginkgolic Acids: Secondary Metabolites from Ginkgo biloba |
| - | Review, | Nor, | NA |
| 7227- | GAs, | Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports |
| - | Review, | Nor, | NA |
| 1186- | GAs, | Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis |
| - | in-vitro, | PC, | NA | - | in-vitro, | Nor, | HUVECs | - | in-vivo, | PC, | NA |
| 7197- | GBE, | Ginkgo biloba for cognitive impairment and dementia |
| - | Review, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 7189- | GBE, | Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx] |
| - | Trial, | NA, | NA |
| 7218- | GBE, | Efficacy and Safety of Ginkgo biloba in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis |
| - | Review, | Stroke, | NA |
| 790- | Ge-132, | A Toxicological Evaluation of Germanium Sesquioxide (Organic Germanium) |
| - | vitro+vivo, | NA, | NA |
| 7117- | Ge-132, | Organogermanium suppresses cell death due to oxidative stress in normal human dermal fibroblasts |
| - | in-vitro, | Nor, | NA |
| 7125- | Ge-132, | A review of public and environmental consequences of organic germanium |
| - | Review, | Nor, | NA |
| 7124- | Ge-132, | Physiological Activity of Trace Element Germanium including Anticancer Properties |
| - | Review, | Var, | NA |
| 7101- | Geld, | Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs |
| - | in-vitro, | Nor, | NA |
| 7098- | Geld, | Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy |
| - | Review, | Var, | NA |
| 7097- | Geld, | Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry |
| - | Review, | Var, | NA |
| 7108- | GEN, | Genistein: A Review on its Anti-Inflammatory Properties |
| - | Review, | Nor, | NA |
| - | Trial, | Pca, | NA |
| 7110- | GEN, | Genistein |
| - | Review, | AD, | NA |
| 7112- | GEO2, | Hazard assessment of germanium supplements |
| - | Review, | Var, | NA |
| 7113- | GEO2, | Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide |
| - | Review, | Nor, | NA |
| 7116- | GEO2, | Analytical product study of germanium-containing medicine by different ICP-MS applications |
| - | Study, | Nor, | NA |
| 7120- | GEO2, | Germanium dioxide-induced nephropathy: a new type of renal disease |
| - | Human, | Var, | NA |
| 7121- | GEO2, | Subacute nephrotoxicity of germanium dioxide in the experimental animal |
| - | in-vivo, | Nor, | NA |
| 7122- | GEO2, | Nephrotoxicity of germanium compounds: report of a case and review of the literature |
| - | Case Report, | Var, | NA |
| 7115- | GeS, | A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study |
| - | Trial, | lymphoma, | NA |
| 7114- | GeS, | A phase II study of spirogermanium in advanced human malignancy |
| - | Human, | Var, | NA |
| 7286- | GGB, | Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | PC9 |
| - | Trial, | BC, | NA |
| 7137- | GI, | 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 | - | vitro+vivo, | Pca, | HMVP2 |
| 7155- | GI, | BSB, | Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer |
| - | Trial, | BC, | NA |
| 7158- | GI, | Ginger-partitioned moxibustion in the prevention of nausea and vomiting induced by chemotherapy in lung cancer:a randomized controlled trial |
| - | Trial, | Lung, | NA |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| 7260- | Gink, | Ginkgetin: A natural biflavone with versatile pharmacological activities |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 7305- | GoldNP, | Rad, | The use of gold nanoparticles to enhance radiotherapy in mice |
| - | in-vivo, | Var, | NA |
| 7304- | GoldNP, | Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine |
| 7320- | Gos, | AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma |
| - | Trial, | Melanoma, | NA |
| 7316- | Gos, | PacT, | carbop, | Chemo, | A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors |
| - | Trial, | Var, | NA |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| - | in-vitro, | NMSC, | A431 | - | in-vitro, | NMSC, | UW-BCC1 | - | in-vitro, | Nor, | NHEKn |
| 842- | Gra, | Phytochemical screening, anti-oxidant activity and in vitro anticancer potential of ethanolic and water leaves extracts of Annona muricata (Graviola) |
| - | in-vitro, | NA, | NA | - | in-vitro, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1025 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid